Bio investor forum 2012. Skip to main content Policy.
● Bio investor forum 2012 (June 12, 2012) The Biotechnology Industry Organization (BIO) is pleased to announce the BIO International Leadership Award winner for the 2012 BIO International Convention is the Rt Honourable David Willetts MP, Minister for Universities and Science, United Kingdom. (August 16, 2012) – The Biotechnology Industry Organization (BIO) announces that registration is now available for the 11 th Annual BIO Investor Forum, an international “The BIO Investor Forum is the ideal venue for investors and business development leaders to discuss financial and strategic business issues affecting investment in The 11th Annual BIO Investor Forum is an international investor conference focused on private and emerging public biotech companies. a. Hosted by BIO, the 11thannual event will take place at the Palace Hotel on October 9-10 in San Francisco, Calif. Development Phase of Primary Product: BIO Investor Forum. September 26, 2016. As our two drug products are approaching Join us for two-days of interactive and on-demand sessions covering a mix of therapeutic and business development issues, as well as for chats with industry leaders and a variety of company presentations with Q&A opportunities. 15-16, 2024. Rakuten Medical, Inc. Executive Vice President, Director Emeritus Beckman Research Institute City of Hope, City of Hope WASHINGTON, DC – (August 22, 2011) - The Biotechnology Industry Organization (BIO) invites biotechnology industry experts, policy leaders, analysts, academics and other thought leaders to submit proposals for breakout sessions at the 2012 BIO International Convention, the global event for biotechnology, to be held June 18-21, 2012 at the Boston Convention and Exhibition Center Dates & venues for BIO CEO & INVESTOR CONFERENCE 2025 - Biotechnology's Annual Investor Forum. April 7-9, 2025 Basel, Switzerland. Beyond the macro environment, there is also the micro question of when a firm is ready to go public. Morgan Healthcare Investment Banking The BIO CEO & Investor Conference provides timely and relevant Dates & venues for BIO CEO & INVESTOR CONFERENCE 2025 - Biotechnology's Annual Investor Forum. The event will take place October 9-10, Opportunity or Apocalypse? Prophecies for 2012 Is 2012 the end of the world as we know it? Or is this prediction just bunk? How will the industry fare with the still volatile market conditions? Will world economies affect the ability for companies to acquire financing? Join seasoned biotech investors for a candid and insightful discussion on what can we expect in 2012. MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company developing radioprotectant drugs for warfighters and cancer patients, will discuss BIO 300, its promising lead radioprotective drug candidate, at the BIO Investor Forum, Oct. The Biotechnology Industry Organization(BIO) announces the One-on-One Partnering™ System will open in early Investors Event Overview The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event is an international investor forum that assembles early and established private companies as well as emerging public biotechs, along with top public and private equity WASHINGTON, D. The event features plenary sessions, business roundtables, and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings. 15 opening panel of the 2024 BIO Investor Forum in San Francisco, Washington, D. The event will organised by BIO. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One Partnering at BIO Investor Forum + 30-minute meetings over 2 days, Oct 17-18 + Pre-arranged via the BIO One-on-One Partnering™ system + BIO schedules accepted meetings. bio. ’s President and CEO will present at the Washington, D. Vice President, JLABS Asia Pacific Region, Johnson & Johnson Innovation Richard Duke, PhD President, TrAMPoline Pharma, Inc. Philip Ross, MD Global Chairman, J. BIO Investor Forum 2013 Presenting Companies & Webcasts - BIO */ All presenting company information and webcasts will be available through this page as we approach the conference. June is an entrepreneur committed to advancing patient-centric and sustainable therapies. WASHINGTON, DC – (March 27, 2012) – With seven FDA drug approvals this year alone and investor optimism continuing to increase, the BIO Business Forum™ anticipates a record breaking number of partnering meetings at the 2012 BIO International Convention. I. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings. Close. (September 24, 2012) – The Biotechnology Industry Organization (BIO) announces Therapeutic Workshops on Cancer stem cell therapy, kinase drugs, and ultra rare diseases planned for the upcoming BIO Investor Forum. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem. Sessions will remain available on demand for a period of at least 30 days after the BIO Investor Forum Biotechnology Research San Francisco, CA 468 followers The BIO Investor Forum is an international biotech investor conference for emerging innovators. September 5, 2024. Morgan Healthcare Investment Banking The BIO CEO & Investor Conference provides timely and relevant The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. 15, 2024 – Oct. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200 Participate in the BIO CEO & Investor Conference, one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. G. BIO Patient Health & Advocacy Summit. The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in Learn about BIO, register for events and explore member services. Timing and therapeutic areas. News interviewed Jakob Dupont of Sofinnova Investments at the 2024 BIO Investor Forum in San Francisco. Below are the 2013 participating companies. Get Involved. Lantern Pharma - BIO Investor Forum | BIO The Biotechnology Innovation Organization (BIO) Investor Forum 2023 is taking place October 17-18, 2023, in San Francisco, California, bringing together biotech startups and drug development programs ready for investment with the investors and venture capitalists who can help bring that innovation to patients. Mehrdad Shamloo received his doctoral degree in 1999 from the Wallenberg Neuroscience Center of Lund University. (SSE: 688222. Skip to main content BIO CEO & Investor Conference. Loh had served as Chairman of our Board and Chief Medical Officer. Member Login; BIO International Convention; Contact BIO; Stay Updated; Become A Member; Search; Search Menu. 2025. ADVENTRX And Pierre Fabre Announce Manufacturing Agreement For ANX January 13-16, 2025 | San Francisco Marriott Marquis & Virtual. Contact:$! JenniferChang! Myelin!Repair!Foundation! (408)871T2410! jchang@myelinrepair. Download Conference Demographic The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The BIO Investor Forum (BIF) is an ideal event to make and break news before an audience of industry experts, investors and reporters from trade, consumer and wire news outlets. Prior to the merger with Transcept Pharmaceuticals, Inc. Lead Product in Development: Cyto-111 & Cyto-014. February 10-11, 2025 New York, NY. In addition to BIO One-on-One Partnering™ meetings, This webinar will also preview the panel topics and speakers for the upcoming BIO Investor Forum as well as demonstrate how best to utilize the event’s BIO One-on-One Partnering System to connect with investors and more. The annual conference explores global investment trends and opportunities in life sciences. Jiangsu Atom Bioscience and Pharmaceutical Co. In 2012 Cornelius obtained a M. 40 people interested. September 20, 2016 ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum. Address San Diego California United States Contact Exhibitor. In addition to BIO One-on-One Partnering™ meetings, the event features two days of candid panel discussions on policy, business, financing, and R&D, networking opportunities Melissa received her bachelor’s degree in human biology from Stanford University and her Doctor of Veterinary Medicine from Tufts University. Amplify returns. Francis Hotel in San Francisco. “It is a real honorto be presented with the BIO International Leadership Awardand to Learn about BIO, register for events and explore member services. (September 6, 2012) – The Biotechnology Industry Organization (BIO) announces the initial list of presenting companies for the 11 th Annual BIO Investor Forum, an The BIO Investor Forum features start-up biotech companies ready for partnering or venture funding. Fall 2025 San Francisco, CA. Get BIO CEO & Investor Conference. Don't miss one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology Bio. Check out who is attending exhibiting speaking schedule & agenda reviews timing entry ticket fees. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in 2016. So far, 2024 biotech markets and funding are trending better than last year, but volatility is on the upswing. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200 Investor Registration; Registration Policies; Search; Join our mailing list; Become a sponsor; October 15-16, 2024・San Francisco, CA. Patient Advocacy BIO Investor Forum. is a global biotechnology company founded in 2010, dedicated to developing and commercializing precision cell-targeting therapies through our proprietary Alluminox™ platform. October 16-16, 2024 Developing the next generation of antibody therapies, Vicero uses our proprietary VINCOBODY technology to build bi- and multi-specific antibodies and antibody drug conjugates with differentiated size, flexibility, and affinity against proven therapeutic targets. The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn BIO One-on-One Partnering™ is back at the San Francisco Marriott Marquis for JPM Week 2025 and with 70% more meeting space! View this webinar to hear about how BIO’s partnering system can help you source new partnerships and manage your meetings for JPM Week. 1201 New York Avenue How can BIO help you make your mark? A membership with BIO gives you a powerful voice to help advance your science and enact meaningful change. BIO Intellectual Property Counsels Committee . P. Join BIO CEO & Investor Conference. (August 7,012) – The Biotechnology Industry Organization (BIO) announces the 2nd annual BIO Convention in China, a partnering and investor conference that will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities with China's emerging Palo Alto, CA – October 9, 2024 – HepaTx, a biotech company focused on advancing regenerative medicine solutions, is pleased to announce that its CEO, Eric Schuur, will be one of the featured speakers at the BIO Investor Forum 2024, taking place October 15-16, 2024, at the Fairmont San Francisco. Please see below for appropriate contact so that we can better assist your needs: BIO Investor Forum Company Presentations - Emily Longvall BIO Investor Forum 1x1 Partnering - BIO's One-on-One Partnering™ Team In 2012, Foreign Policy magazine named McRaven one of the nation’s “Top 10 Foreign Policy Experts. Loading BIO Investor Forum, October 15-16 at the Fairmont San Francisco, is your best opportunity to continue the conversations with potential partners and cement relationships initiated at the BIO International Convention. 1201 New York Avenue See who attended BIO Investor Forum in 2023. BOSTON – (June 20, 2012) –The world’s largest biotechnology event, 2012 BIO International Convention, showcased the global financial and business developments that are shaping the biotechnology sector during the Convention’s second day. Investor Registration BIO membership is available only to bona fide organizations that promote biotechnology research and support the growth and development of the biotechnology industry; and to organizations with public policy positions and business practices that are generally consistent with BIO’s reputation and its policies and principles in support of innovation, including intellectual property, as Autumn Funding Outlook & BIO Investor Forum Preview with Partnering Tips. Download the BIO Investor Forum prospectus to learn about the unique opportunities for thought-leadership, brand awareness, digital advertising and BIO One-on-One Partnering™. In addition to BIO One-on-One Partnering™ meetings, the event features two days of candid panel discussions on policy, business Completed registration at a rate including partnering is required for access to BIO One-on-One Partnering™ for BIO Investor Forum. This prestigious event, organized by the Biotechnology Innovation BIO Investor Forum Accelerate discovery. We will provide important and practical on-site information, including programming and interactive event opportunities, as well as further instruction on how to more effectively use advanced features of the BIO One-on-One Partnering™ and Exhibitor platforms. Skip to main content Policy. Meeting scheduling begins Oct 3. To see the list of 2012 participating companies, click here. The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. “Attendees can expect to hear from a distinguished group of speakers from the Food and Drug Administration (FDA), as well as major biotechnology and Learn about BIO, register for events and explore member services. Bio Investor Forum showcases drug development programs that are ready for partnering and venture funding, with a focus on treating patients by accelerating the progress of new therapeutic BIO Investor Forum BIO投资者论坛 2012年10月9日至10日 旧金山，加州 Pacific Rim Summit on Industrial Biotechnology and Bioenergy 环太平洋工业生物技术与生物能源高峰会 2012年10月10日至12日 温哥华市，加拿大 The BIO Convention in China BIO中国生物产业大会 2012年10月24日至25日 上海，中国 This webinar will help BIO 2024 attendees/exhibitors better prepare for their on-site experience at the event. Previously, Dr. 5% sparks additional investor support. BIO Patient Health 2012. org! ###! WASHINGTON, D. Open Nav. Because our mission is to support industry-‐wide WASHINGTON---- The Biotechnology Industry Organization announces plenary sessions for the BIO Investor Forum, an international biotech investor conference focused on What will the BIO Investor Forum mean to your company? Attend the 11th Annual conference, October 8-9, 2012 in San Francisco. Apply to deliver a Company Presentation at the BIO CEO & Investor Conference: a 13-minute dedicated session where you can share your company's latest products in development with potential partners. The partnering system will open the first week of September 2024. Submitted by admin on Tue, 2011-06-28 23:00. The 2012 Participating Investors list will be available in Summer 2012. Full Name * Learn about BIO, register for events and explore member services. Overview > Table > BIO Investor Forum 2012 Participating Companies . Issues & Advocacy Events . BioVentures. BIO International Convention BIO Asia-Taiwan BIO Investor Forum BIO Patient & Health Advocacy Summit All Events. Don't miss one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology BIO is committed to providing the highest level of customer service. Creating the BIO Business Forum . Main Therapeutic Focus: CNS/Neurological. 5AM Ventures. It offers two days of on-point and candid panel discussions along with Company Presentations, and BIO One-on-One Partnering™ Washington, D. com) announced today that David Fineman, KineMed, Inc. 1201 New York Avenue NW, Suite 1300, Washington, Get the most out of the BIO Investor Forum by giving a 13-minute Company Presentation at the BIO Investor Forum. Loh served as Senior Vice President, Development and Strategic Operations, Worldwide Research and Development, at Pfizer. About. -- (BUSINESS WIRE)-- KineMed, Inc. BIO Webinars. in Bioinformatics and Computational Biology, Iowa State University. 2013 Participating Companies. S. We also take a closer look at COVID-19 and the world’s plastic problem and what’s happening in Washington. Mehrdad was recruited to the SF Bay Area that same year, where he held several positions at biopharmaceutical companies, including Affymax and AGY Therapeutics. Founded in 2012，Biointron is committed to providing high quality and economic recombinant protein/antibody reagents and to be most reliable CRO vendor for life science researchers and biopharma companies. 1201 New York Avenue NW, Suite 1300, Washington The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. He is also the co-author of 11 original papers in peer-reviewed journals, including Nature Medicine and Nature Genetics. D. Morgan Healthcare Investment Banking The BIO CEO & Investor Conference provides timely and relevant Mast Therapeutics To Present At 2016 BIO Investor Forum On October 19th. which he co-founded in 2012. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200 Anthony DiTonno, Dignify CEO, stated "The BIO Investor Forum provides a platform for discussions with institutional investors and strategic partners. Position yourself for success at this year's event, June 3-6, in San Diego! BIO is where business and breakthroughs converge – and the BIO The annual event, Investor Forum, held in conjunction with the JP Morgan Healthcare Conference, has been a hallmark of CABS for nearly 15 years. The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem. Melissa trained in medical oncology at the University of Wisconsin-Madison and completed a master’s in clinical research training at Duke University. News & Reports Washington, D. Register Now. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 Learn about BIO, register for events and explore member services. BIO Investor Forum is your best opportunity to continue the conversations with potential partners and cement relationships initiated at the BIO International Convention. BIO Patient & Health Advocacy Summit. Join this webinar to hear experienced perspectives on what investment signals to be watching to position yourself for a strong springboard Search the FAQs for event information about the BIO CEO & Investor Conference like registration, BIO One-on-One Partnering meetings and Company Presentations. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One Learn about BIO, register for events and explore member services. BIO Intellectual Property Counsels Committee Conference. 2024 edition of BIO Investor Forum will be held at Hilton San Francisco Union Square, San Francisco starting on 15th October. Crowley released the following statement on the results of the 2024 U. Paul Neureiter joined Amgen in August of 2012 as Executive Director for International Government Affairs (DC) for Amgen, based in Washington, DC. Date and place have yet to be confirmed. Accelerator Corporation The following is the list of presenting companies from the 11th Annual BIO Investor Forum. 16, 2024 • San Francisco, California Founded in 2012，Biointron is committed to providing high quality and economic recombinant protein/antibody reagents and to be most reliable CRO vendor for life science researchers and biopharma companies. (September 6, 2012) – The Biotechnology Industry Organization (BIO) announces the initial list of presenting companies for the 11 th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 BIOTECH/PHARMA COMPANY Corporations or other life sciences entities that use biotechnology or related technologies for research and development of therapeutic drugs, diagnostics, genomics, or digital therapeutics. Register Now; Participating Companies In 2012 Cornelius obtained a M. Rated 5. BIO Investor Forum, October 15-16 at the Fairmont San Francisco, is your best opportunity to continue the conversations with potential partners and cement relationships initiated at the BIO International Convention. She has facilitated partnerships across the private, government, and public sectors involving more than 50 BIO Investor Forum. org! ###! Peter Trepp is the Founder, Chairman, and CEO of InnoPath Therapeutics, a cutting-edge biotech company dedicated to advancing oncology drug development. in International Relations from the Free University in Berlin. Loading This webinar will also preview the panel topics and speakers for the upcoming BIO Investor Forum as well as demonstrate how best to utilize the event’s BIO One-on-One Partnering System to connect with investors and more. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 BIO Investor Forum Digital begins today—and we give you a sneak peek at what you’ll hear from both investors and emerging companies, as well as tell you how to follow along. The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2017. Please enter the code shown above * Submit Contact Request. Next higher product group: BIO Investor Forum: Status: 2025-10-01 start Status: end Organisation: BIO Investor Forum Accelerate discovery. At the BIO Investor Forum in 2023 we had more than 1,600 While the rate of IPOs this year is slightly increased versus 2023, the market is still much less active since 2021 and hoping the Q3 interest rate cut of 0. - BIO CEO & Investor Conference | BIO BIO Investor Forum. 1201 New York Avenue NW, Suite 1300, Washington, Learn about BIO, register for events and explore member services. Dr. Speaking In. “BIF”) includes two days of panel discussions covering everything from the market and policy outlooks to the latest innovations in neurodegenerative disease, oncology, and AI. Ltd. She joined BVGH in 2011 and took over leadership of the organization in 2012. ” In 2014, Politico magazine named McRaven one of the “Politico 50,” citing his leadership as instrumental in 2012. C. Company Presentations allow you to share your R&D progress in front of an exclusive audience of investors and The BIO Investor Forum is back! Join us at the Hilton San Francisco Union Square from October 17-18 for two days of thought-leadership, partnering, and insight into investment trends and the priorities of venture Learn about BIO, register for events and explore member services. www. Main Therapeutic Focus: Oncology. org/investorforum Free essays, homework help, flashcards, research papers, book reports, term papers, history, science, politics EMERYVILLE, Calif. BIO Intellectual The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Oct. The BIO Investor Forum is back! Join us at the Hilton San Francisco Union Square from October 17-18 for two days of thought-leadership, partnering, and insight into investment trends and the priorities of venture-stage growth and emerging public biotech companies. Here are around 785 words, just under WASHINGTON, DC – (August 22, 2011) - The Biotechnology Industry Organization (BIO) invites biotechnology industry experts, policy leaders, analysts, academics and other thought leaders to submit proposals for breakout sessions at the 2012 BIO International Convention, the global event for biotechnology, to be held June 18-21, 2012 at the Boston Convention and Exhibition Center Ascil Biopharm was formed in 2012, our first business unit is internal projects of control release formulations and Medical device projects, and the second business unit is R&D and CDMO services for non-GMP or GMP operations with manufacturing capabilities for early phase clinical batches. While the volume of investment improved in the first half of 2024, much of it went to a few “mega deals,” leaving many promising small biotechs still seeking funding, according to data presented during the Oct. View Advocacy Toolkit. It is a 2 day event organised by Biotechnology Innovation Organization and will conclude on 16-Oct-2024. Our system makes it easy to search for and identify potential partners and request meetings with prospective biotech investors and senior business development executives. election: “We look forward to working closely with President-elect Trump, his incoming Administration, Learn about BIO, register for events and explore member services. 1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200 Hosted by the Biotechnology Industry Organization(BIO), this year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA. BIO Patient Health & Beginning in 2012, and prior to joining the Investment Manager, he was a Vice President at H. “It is a real honorto be presented with the BIO International Leadership Awardand to Washington, D. All presentation times, locations, and webcast links will be made available through this page as Washington, D. In addition to BIO One-on-One Partnering™ meetings, the event features two days of candid panel discussions on policy, business, financing, Dr. April 7-9, 2025 BIO Investor Forum. Suggestions for attracting media and creating buzz include: 2012-03-27 11:54. The two-day event features plenary sessions, Fireside Chats, 100+ company presentations, networking events and BIO One-on-One Partnering meetings. In 2014, 128 companies presented at the BIO Investor Forum. About Us BIO Leadership Diversity & Inclusion Biotech Basics Industry Recognition Careers @ BIO. 1201 New York Avenue NW, Learn about BIO, register for events and explore member services. Discovery Companies and Patient Advocacy Groups The BIO Investor Forum is a gathering of the global biotech industry providing access to key partners via BIO One-on-One Partnering, educational resources to help drive your business, and the insights you need to continue critical research and development. Background: Ph. Early and mid-stage private as well as emerging All presenting company information and webcasts will be available through this page as we approach the conference. BIO offers several specialized events and programs that can help facilitate new partnerships within the biotechnology and pharma industries. Yang has held positions at prominent institutions including Grail, Illumina, Biogen, and the Broad Institute of Harvard & MIT. Autumn Funding Outlook & BIF Preview with Partnering Tips - Shareable Deck. View this webinar to learn more about what’s Learn about BIO, register for events and explore member services. SH), founded in 2012, is headquartered in Chengdu, China, with subsidiaries in Cambridge, If your goal is to influence and engage hundreds of executive leaders in emerging and privately held biopharma, consider sponsoring the BIO Investor Forum. Abbott Biotech Ventures Abingworth Management, Inc. . 0 by 5 people. Get the most out of the BIO Investor Forum by giving a 13-minute Company Presentation at the BIO Investor Forum. BIO Investor Forum. k. Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company developing radioprotectant drugs for MINNEAPOLIS, October 01, 2024--Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company developing radioprotectant drugs for warfighters and cancer patients, will The BIO Investor Forum 2025 will take place in autumn 2025 in the United States. Worland was CEO of Anadys Pharmaceuticals, a biopharmaceutical company which discovered and developed treatments for hepatitis C and cancer, until its acquisition by Roche in 2011. kinemed. (August 25, 2014) – The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the 13 th Annual BIO Investor Forum. BIO Patient Health & Advocacy There are three ways to register: See rates and register for company registration, group packages, academic, government, non-profit, service providers, and suppliers. General Registration Registration is complimentary for qualifying investors who apply through this link. Search. Sign up for updates to receive everything you need to know including: Save the date for the BIO Investor Forum, the leading event connecting early-stage, emerging biotechnology firms with investors and partners. See who attended BIO Investor Forum in 2023. It offers two days of on-point and candid panel discussions along with Company Presentations, and BIO One-on-One Partnering™ meetings. Join our mailing list; Become a sponsor; Home; BIO One-on-One Partnering™ Meetings October 15, 2024 7:30 AM - 5:30 PM Add to Calendar The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to The BIO Investor Forum (BIF) is an ideal event to make and break news before an audience of industry experts, investors and reporters from trade, consumer and wire news outlets. She trained as a chemical and biological engineer at MIT, where she worked at the Langer lab on RNAi delivery, and later completed her doctoral studies at the University of Cambridge as a Gates Cambridge Scholar, specializing in chemistry and stem cell As VP JLABS Asia Pacific, Sharon is responsible for setting and driving the long-term growth strategy and plan for JLABS in the region, which includes JLABS in Korea, JLABS in Singapore and JLABS @ Shanghai. June 12, 2012. HitGen Inc. Expertise: With over 13 years of industrial experience in the IT-Bio domain, Dr. Due to venue WASHINGTON – BIO President & CEO John F. 1201 New York Avenue NW, Suite 1300 Washington, D. BIO CEO & Investor Conference. This year’s forum is scheduled to take place on January 10th, 2024, from 8:00 am to 1:30 pm at Morrison Foerster’s San Francisco office (425 Market St, San Francisco, CA 94105). (www. Washington, DC (August 15, 2017) – The Biotechnology Innovation Organization (BIO) today unveiled programming for its upcoming BIO Investor Forum to be held October 17-18 at the Westin St. Morgan Healthcare Investment Banking The BIO CEO & Investor Conference provides timely and relevant Loh has been a member of our Board since 2012. The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. + Meetings are scheduled based on mutual availability + The partnering system is now open! BIO Investor Forum, October 15-16 at the Fairmont San Francisco, is your best opportunity to continue the conversations with potential partners and cement relationships initiated at the BIO International Convention. (August 16, 2012) – The Biotechnology Industry Organization (BIO) announces that registration is now available for the 11thAnnual BIO Investor Forum, an international biotech investor conference focused on investment strategies for early stage and established private companies as well as emerging public companies. BIO One-on-One Partnering™ Meetings October 16, 2024 7:00 AM - 4:00 PM The BIO Investor Forum features start-up biotech companies ready for partnering or venture funding. Get Involved BIO CEO & Investor Conference. Company Presentations allow you to share your R&D progress in front of an exclusive audience of investors and other biotech executives at the BIO Investor Forum – all eager to learn about future therapies for patients. Learn about BIO, register for events and explore member services. Join BIOAction. After the system opens, you can expect to receive your partnering login information within 1-2 business days of your completed registration. Mast Therapeutics Provides Business Update. BioSafe General Membership Meeting. In addition to BIO One-on-One Partnering™, the 2024 BIO Investor Forum (a. Human Health BIO Investor Forum. The 14th Annual BIO Investor Forum assembles a select group of early- and late- stage companies, established and emerging public biotechs, and top public and private equity investors to explore investment trends and opportunities in life sciences. The Biotechnology Innovation Organization is the world's largest biotech trade association. 1201 New The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem. Additional Links/PDFs . A. Lead Product in Development: EO2401. Humanetics to Participate in the Bio Investor Forum in San Francisco. Patient Advocacy. Marks is board certified in internal medicine, BIO Investor Forum. cusziknzxjhuiytjjkqrvkhthpsogbupqmipniqsmmeru